WHO ICTRP trial
A comparison of regular and as-needed use of Mometasone furoate hydrate nasal…
JPRN-UMIN000001644 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000001644 |
|---|---|
| Public title | A comparison of regular and as-needed use of Mometasone furoate hydrate nasal spray in the treatment of Japanese cedar pollinosis |
| Scientific title | A comparison of regular and as-needed use of Mometasone furoate hydrate nasal spray in the treatment of Japanese cedar pollinosis - Mometasone furoate hydrate nasal spray for pollinosis: regular versus as-needed use |
| Primary sponsor | Department of Otorhinolaryngology, Head & Neck Surgery, Faculty of Medicine, University of Yamanashi |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Japanese cedar pollinosis |
| Interventions | Regular use group: Taking two puffs of Mometasone furoate hydrate nasal spray into each nostril (total 200 ug/day) every morning from the onset of nasal symptoms. As-needed use group: Taking two puffs of Mometasone furoate hydrate nasal… |
| Registration date | Jan 17, 2009 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: